Loading...
Talk of a “Default” Drug Formulary Rattles Industry: CMS Could Move in That Direction for Marketplace Plans After 2019, but the Discussion Has Already Started
A proposed CMS rule promising to consider a federal default prescription drug benefit after 2019 has startled manufacturers, pharmacy benefit managers, P&T committees, and pharmacies alike. We consider the rationale and potential effects of such a rule.
Na minha lista:
| Udgivet i: | P T |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MediMedia USA, Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5768297/ https://ncbi.nlm.nih.gov/pubmed/29386865 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|